Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleBasic Science Investigations

Photoimmunotherapy Targeting Prostate-Specific Membrane Antigen: Are Antibody Fragments as Effective as Antibodies?

Rira Watanabe, Hirofumi Hanaoka, Kazuhide Sato, Tadanobu Nagaya, Toshiko Harada, Makoto Mitsunaga, Insook Kim, Chang H. Paik, Anna M. Wu, Peter L. Choyke and Hisataka Kobayashi
Journal of Nuclear Medicine January 2015, 56 (1) 140-144; DOI: https://doi.org/10.2967/jnumed.114.149526
Rira Watanabe
1Molecular Imaging Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hirofumi Hanaoka
1Molecular Imaging Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kazuhide Sato
1Molecular Imaging Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tadanobu Nagaya
1Molecular Imaging Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Toshiko Harada
1Molecular Imaging Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Makoto Mitsunaga
1Molecular Imaging Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Insook Kim
2Applied/Developmental Research Directorate, Leidos Biomedical Research Inc., Frederick National Laboratory, Frederick, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chang H. Paik
3Nuclear Medicine Department, Radiology and Imaging Science, Warren Grant Magnuson Clinical Center, National Institutes of Health, Bethesda, Maryland; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anna M. Wu
4Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter L. Choyke
1Molecular Imaging Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hisataka Kobayashi
1Molecular Imaging Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • FIGURE 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1.

    Differential interference contrast and fluorescence microscopy of photoimmunotherapy-treated mix of PC3pip (PSMA-positive) and flu (PSMA-negative) cells. Cells were incubated with anti-PSMA antibodies (IgG-IR700), Mbs (Mb-IR700), or Dbs (Db-IR700) at 10 μg/mL. Just after fluorescence imaging, only PSMA-positive cells demonstrate necrotic cell death (cell budding/rupture). Scale bar = 50 μm. PIT = photoimmunotherapy.

  • FIGURE 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 2.

    Target-specific cell death in response to IgG-, Mb-, or Db-IR700–mediated photoimmunotherapy in PSMA-positive (A) or -negative (B) cells. Target-specific cell death in response to photoimmunotherapy was dose-dependent to intensity of irradiation. Data are mean ± SEM (n ≥ 3).

  • FIGURE 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 3.

    Analysis of in vivo biodistribution of radioactivity after injection of 125I-PSMA-IgG (A), Mb (B), or Db (C) into mice bearing PSMA positive (PSMA+) and negative (PSMA−) tumors. Each value was calculated using percentage injected dose per gram of tissue (Supplemental Fig. 1) for each animal and represented as mean ± SEM (n = 3–5): ratios of each organ and tumor to blood (left), subtraction of PSMA-negative tumor from PSMA-positive tumor (center), and ratios of PSMA-positive tumor to PSMA-negative tumor (right). * = value cannot be calculated because some denominators are 0.

  • FIGURE 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 4.

    Tumor volume and survival curves of PSMA-positive tumor-bearing mice. Mice were randomized to 1 of 3 groups at 3 d after tumor cell injection (n = 9–10). IgG-IR700 (A), Mb-IR700 (B), or Db-IR700 (C) was injected, and photoimmunotherapy was performed at 1 and 2 d after injection for IgG-IR700 or Mb-IR700 and at 6 h and 1 d after injection of Db-IR700. Mice were observed until tumor volume reached more than 500 mm3, at which time mice had to be euthanized. *P < 0.05 vs. control, Dunnett multiple-comparison test. #P < 0.05 vs. control, log-rank test. Ab = antibody.

PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 56 (1)
Journal of Nuclear Medicine
Vol. 56, Issue 1
January 1, 2015
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Photoimmunotherapy Targeting Prostate-Specific Membrane Antigen: Are Antibody Fragments as Effective as Antibodies?
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Photoimmunotherapy Targeting Prostate-Specific Membrane Antigen: Are Antibody Fragments as Effective as Antibodies?
Rira Watanabe, Hirofumi Hanaoka, Kazuhide Sato, Tadanobu Nagaya, Toshiko Harada, Makoto Mitsunaga, Insook Kim, Chang H. Paik, Anna M. Wu, Peter L. Choyke, Hisataka Kobayashi
Journal of Nuclear Medicine Jan 2015, 56 (1) 140-144; DOI: 10.2967/jnumed.114.149526

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Photoimmunotherapy Targeting Prostate-Specific Membrane Antigen: Are Antibody Fragments as Effective as Antibodies?
Rira Watanabe, Hirofumi Hanaoka, Kazuhide Sato, Tadanobu Nagaya, Toshiko Harada, Makoto Mitsunaga, Insook Kim, Chang H. Paik, Anna M. Wu, Peter L. Choyke, Hisataka Kobayashi
Journal of Nuclear Medicine Jan 2015, 56 (1) 140-144; DOI: 10.2967/jnumed.114.149526
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • Acknowledgments
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • Differences in Therapeutic Efficacy in Pancreatic Cancer Between Interstitial and Superficial Light Delivery Strategies in Targeted Photo Therapy
  • Syngeneic Mouse Models of Oral Cancer Are Effectively Targeted by Anti-CD44-Based NIR-PIT
  • Near-Infrared Photoimmunotherapy Targeting Prostate Cancer with Prostate-Specific Membrane Antigen (PSMA) Antibody
  • Near Infrared Photoimmunotherapy in a Transgenic Mouse Model of Spontaneous Epidermal Growth Factor Receptor (EGFR)-expressing Lung Cancer
  • Establishment of the In Vivo Efficacy of Pretargeted Radioimmunotherapy Utilizing Inverse Electron Demand Diels-Alder Click Chemistry
  • Theranostic Agents for Photodynamic Therapy of Prostate Cancer by Targeting Prostate-Specific Membrane Antigen
  • Google Scholar

More in this TOC Section

  • 11C-Methionine PET of Myocardial Inflammation in a Rat Model of Experimental Autoimmune Myocarditis
  • Counting Rate Characteristics and Image Distortion in Preclinical PET Imaging During Radiopharmaceutical Therapy
  • Design and Fabrication of Kidney Phantoms for Internal Radiation Dosimetry Using 3D Printing Technology
Show more Basic Science Investigations

Similar Articles

Keywords

  • Photoimmunotherapy
  • prostate specific membrane antigen
  • monoclonal antibody
  • diabody
  • minibody
  • pharmacokinetics
SNMMI

© 2025 SNMMI

Powered by HighWire